Research analysts at Credit Suisse initiated coverage on shares of National Bank of Greece (NYSE:NBG) in a report released on Wednesday, TheFlyOnTheWall. National Bank of Greece (ADR) (NYSE:NBG) net profit margin is 10.00% and weekly performance is 4.23%. On last trading day company shares ended up $3.94. Analysts mean target price for the company is $4.65. National Bank of Greece (ADR) (NYSE:NBG) distance from 50-day simple moving average (SMA50) is 2.10%.
The largest satellite radio company in the U.S. – SIRIUS XM Holdings Inc. (NASDAQ:SIRI) – has reached an agreement with Ford Motor Co. to provide Ford customers a five-year subscription to SiriusXM Traffic and SiriusXM Travel Link. These services will be available on all Ford vehicles, starting with 2015 models that are equipped with navigation facility. Sirius XM Holdings Inc. (NASDAQ:SIRI) shares fell -2.02% in last trading session and ended the day on $3.39. SIRI gross Margin is 62.70% and its return on assets is 5.30%.Sirius XM Holdings Inc. (NASDAQ:SIRI) quarterly performance is 1.19%.
Sprint Corporation (NYSE:S) which is trying to acquire T-Mobile Us Inc. (NYSE:TMUS), is said to have been in talks with eight banks to finance its proposed acquisition, Reuters reported. The terms of the financing arrangement are expected to be finalized by July, whereas the deal is expected to be announced by August 2014. Sprint Corporation (NYSE:S) shares moved down -0.59% in last trading session and was closed at $8.41, while trading in range of $8.23 – $8.56. Sprint Corporation (NYSE:S) year to date (YTD) performance is -21.77%.
AT&T Inc. (NYSE:T) is reportedly the latest company to confirm it was victim of a data breach, although in this case the perpetrators were reportedly employees of one of AT&T’s vendors. AT&T Inc. (NYSE:T) ended the last trading day at $35.39. Company weekly volatility is calculated as 0.69% and price to cash ratio as 50.87.AT&T Inc. (NYSE:T) showed a positive weekly performance of 1.03%.
Titan Pharmaceuticals, Inc. (OTCBB:TTNP) a specialty pharmaceutical company developing proprietary therapeutics for the treatment of opioid dependence and other serious medical disorders, announced on 9 June that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for a patent application covering the sustained release of dopamine agonists utilizing ProNeura(TM), Titan’s proprietary long-term drug delivery technology. On last trading day company shares ended up $0.780.